blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4055365

EP4055365 - CHARACTERIZATION OF PARTICLES IN SOLUTION [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  08.12.2023
Database last updated on 06.07.2024
FormerRequest for examination was made
Status updated on  12.08.2022
FormerThe international publication has been made
Status updated on  14.05.2021
Formerunknown
Status updated on  10.11.2020
Most recent event   Tooltip12.06.2024New entry: Reply to examination report 
Applicant(s)For all designated states
NanoTemper Technologies GmbH
Flössergasse 4
81369 München / DE
[2022/37]
Inventor(s)01 / BAASKE, Philipp
Kleinstr. 30
81379 München / DE
02 / DERIX, Jonathan
Hauptstr. 35c
85716 Unterschleißheim / DE
03 / HASLINGER, Robert
Hoflacher Straße 87
82223 Eichenau / DE
 [2022/37]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstraße 3
81675 München / DE
[2022/37]
Application number, filing date20800216.206.11.2020
[2022/37]
WO2020EP81370
Priority number, dateEP2019020818708.11.2019         Original published format: EP 19208187
EP2020019791023.09.2020         Original published format: EP 20197910
[2022/37]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021089834
Date:14.05.2021
Language:EN
[2021/19]
Type: A1 Application with search report 
No.:EP4055365
Date:14.09.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 14.05.2021 takes the place of the publication of the European patent application.
[2022/37]
Search report(s)International search report - published on:EP14.05.2021
ClassificationIPC:G01N15/02, G01N15/00, G01N21/51, G01N33/68
[2022/37]
CPC:
G01N21/6486 (EP,KR,US); G01N15/0211 (EP,KR,US); G01N33/6803 (US);
G01N15/01 (EP,KR,US); G01N21/51 (EP,KR); G01N33/68 (EP,KR);
G01N2015/0038 (EP,KR,US); G01N2015/0092 (EP,KR,US); G01N2015/019 (EP,KR);
G01N2015/0222 (EP,KR,US); G01N2021/0346 (EP,KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/37]
TitleGerman:CHARAKTERISIERUNG VON TEILCHEN IN LÖSUNG[2022/37]
English:CHARACTERIZATION OF PARTICLES IN SOLUTION[2022/37]
French:CARACTÉRISATION DE PARTICULES EN SOLUTION[2022/37]
Entry into regional phase08.06.2022National basic fee paid 
08.06.2022Designation fee(s) paid 
08.06.2022Examination fee paid 
Examination procedure08.06.2022Examination requested  [2022/37]
08.06.2022Date on which the examining division has become responsible
30.12.2022Amendment by applicant (claims and/or description)
12.12.2023Despatch of a communication from the examining division (Time limit: M06)
12.06.2024Reply to a communication from the examining division
Fees paidRenewal fee
23.11.2022Renewal fee patent year 03
22.11.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]US5575977  (MCKINNEY DAVID K [US], et al) [Y] 4,25,37 * column 15, line 1 - line 47; figure 3 *;
 [XAYI]US5973779  (ANSARI RAFAT R [US], et al) [X] 1,3,5,6,9,13,14,17-21,26,28,30 * column 1, line 8 - line 34 * * column 6, line 38 - line 43; figure 1 * * column 8, line 1 - line 63; figure 2 * * column 13, line 26 - line 45; figures 10,11(a),11(b) * * column 14, line 57 - column 15, line 3 * [A] 10-12,29 [Y] 4,25,37 [I] 2,7,8,15,16,21,23-25,27,31-36,38,39;
 [YA]FR2856792  (COMMISSARIAT ENERGIE ATOMIQUE [FR]) [Y] 4 * page 9, line 27 - page 10, line 16 * [A] 3;
 [XAI]US2010136611  (MAURER ELISABETH [CA]) [X] 1,2,5,6,9,13,16,18,26,30 * paragraphs [0005] , [0011] , [0021] , [0045] - [0047] - [0054] , [0065] , [0068] , [0089]; figures 1A,1B,2 * [A] 3,4,29 [I] 7,8,10-12,14,15,17,19-25,27,28,31-39;
 [XAI]EP3159674  (EUROPEAN MOLECULAR BIOLOGY LABORATORY [DE], et al) [X] 1,2,5,6,8-19,27,28,30-33,35,39 * paragraphs [0001] , [0005] , [0015] , [0027] , [0036] , [0037] , [0044] , [0051] , [0078] , [0080] , [0086] , [0089]; figure 1 * [A] 3,4,29,34 [I] 7,20-26,36-38;
 [A]US2018259535  (VERDINE GREGORY L [US], et al) [A] 25,37 * paragraph [0596] *;
 [XYI]US2018313758  (HSIEH VINCENT [US], et al) [X] 1-3,5,6,9-13,16-18,26-32,34,35,38,39 * paragraphs [0008] , [0010] , [0015] , [0022] , [0026] , [0027] , [0037] , [0048]; figure 5 * [Y] 4,25,37 [I] 7,8,14,15,19-25,33,36;
 [A]WO2019166650  (CDR LIFE AG [CH]) [A] 25,37 * paragraph [0221] *;
 [A]WO2019201894  (MERCK PATENT GMBH [DE]) [A] 25,37* page 8, line 34 - line 36 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.